A scientific gamechanger

Editing along ethical boundaries

Editing along ethical boundaries

Commercially available since 2012, CRISPR-Cas9 (CRISPR) edits genes by cutting DNA and letting natural processes repair those divides. This allows scientists to add, remove or alter particular parts of an organism’s genome. Think of it as a geneticist’s “copy and paste” tool. More precise and inexpensive than previous genome engineering, the attributes that make it widespread in the scientific community also expedite the need for ethical consensus among users.

“What happens when the preventive interventions you imagine raise the same kinds of ethical questions that enhancements do?” asked Eric JuengstOpens in new window, director of the UNC Center for Bioethics. “Questions about equal access, effects on the downstream generations, and effects on what it means to be human.”

Juengst explores these and other ethical quandaries as they relate to this gene-editing tool. His work focuses on research ethics — questions raised by new advances in science and technology. He and his colleague, Jean Cadigan, are leading a project that will survey scientists about the professional and social factors that shape the trajectories of using CRISPR in preventive human genome editing, as well as analyzing national and international policy.

Read the complete Carolina Story…Opens in new window

UNC Health Funding Priorities

Readers Also Viewed...

Design of molecular structure with egg hatching

Carolina Scientists Earn Prestigious Keck Award

UNC-Chapel Hill scientists were awarded $1 million from the W.M. Keck Foundation to answer the age-old question: How did life on Earth begin?


‘Heroes Health’ Mental Wellness App Launched By UNC School Of Medicine And UNC Health

“First responders and health care workers are facing a lot of challenges right now.”


UNC Health Mobile Health Clinic

See how the UNC Mobile Health Clinic is increasing access to COVID-19 testing in underserved areas — and at no cost to patients.


Testing a Vaccine

The medical director of the HIV Cure Center is leading a clinical research team to conduct a large phase 3 trial for a COVID-19 vaccine.

Dr. Cindy Gay stands outside a building on UNC-Chapel Hill's campus.

Questions about COVID-19 Vaccines and Vaccine Trials?

Dr. Cindy Gay shares insight about the ins and outs of COVID-19 vaccine trials in this exclusive Q&A.


Uncovering a Hidden Allergy

Researching anomalies to improve the lives of many